Skip to content
ABSI·Nasdaq·US

Absci

Absci is a clinical-stage biopharmaceutical company that uses generative AI and synthetic biology to design and optimize therapeutic candidates, especially biologics. Its revenue comes mainly from partner-funded drug creation collaborations rather than from selling drugs at commercial scale.

Thematic Position

ABSI

Relationship Groups

Partners4
Competitors9

Relationship details are part of the Pro plan.

Recent Discoveries

Recent discoveries are part of the Pro plan.

Ended Relationships

2 ended relationships · Ended relationships are part of the Pro plan.

Management Perspective on Regulatory & Geopolitical Developments

state aidprice controlhealthcare regulation
ACA, Medicaid Drug Rebate Program and IRA increase drug pricing pressure
SEC 10-KMar 24, 2026

The full regulatory passage is part of the Pro plan.

13 more · Regulatory and geopolitical insights are part of the Pro plan.